Literature DB >> 6883322

High proliferation of granulocyte-macrophage progenitors in tumor-bearing mice.

L Balducci, C Hardy.   

Abstract

Cancer may affect hemopoiesis by altering the proliferative status of hemopoietic progenitor cells. In Lewis lung carcinoma (LLC), the proliferative rate of the granulocyte-macrophage colony-forming unit (culture) (GM-CFUc) was studied using in vivo hydroxyurea techniques. The disposal of mature elements to the periphery was also monitored during tumor growth. Neutrophilia, anemia, and splenic hypertrophy developed during the course of the disease. By Day 6 post-tumor implant, myeloid hyperplasia of the marrow was evident, but the content of GM-CFUc in LLC mice was similar to that of control. However, by Day 11, the marrow of LLC mice displayed an increased concentration of GM-CFUc, which tripled by Day 19. There was an increased percentage of proliferating GM-CFUc in LLC mice by Day 6 which was highest by Day 11 and thereafter declined. The level of colony-stimulating activity was higher in the serum of tumor bearers than in that of controls. The early increase in proliferative rate of these early hemopoietic precursors can account for the later accumulation of GM-CFUc and myeloid elements in the marrow. Increased cycling of hemopoietic stem cells raises questions concerning the potential for early exhaustion of hemopoietic progenitor cells in these animals.

Entities:  

Mesh:

Year:  1983        PMID: 6883322

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  Targeting stroma to treat cancers.

Authors:  Boris Engels; Donald A Rowley; Hans Schreiber
Journal:  Semin Cancer Biol       Date:  2011-12-24       Impact factor: 15.707

2.  Induction of tumoricidal macrophages from bone marrow cells of normal mice or mice bearing a colony-stimulating-factor-producing tumor.

Authors:  S Hosoe; T Ogura; S Hayashi; K Komuta; T Ikeda; T Shirasaka; I Kawase; T Masuno; S Kishimoto
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.

Authors:  Ainhoa Arina; Theodore Karrison; Eva Galka; Karin Schreiber; Ralph R Weichselbaum; Hans Schreiber
Journal:  Cancer Immunol Res       Date:  2017-01-11       Impact factor: 11.151

4.  Lack of a relationship between immune function and chemically induced hepatocarcinogenesis in B6C3F1 mice.

Authors:  D R Germolec; R R Maronpot; M F Ackermann; S J Vore; K Dittrich; G J Rosenthal; M I Luster
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.

Authors:  Ainhoa Arina; Karin Schreiber; David C Binder; Theodore G Karrison; Rebecca B Liu; Hans Schreiber
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

6.  Concomitant development of granulocytosis and enhancement of metastases formation in tumor-bearing mice.

Authors:  L Milas; M H Faykus; W H McBride; N Hunter; L J Peters
Journal:  Clin Exp Metastasis       Date:  1984 Jul-Sep       Impact factor: 5.150

7.  Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells.

Authors:  G Heuff; H S Oldenburg; H Boutkan; J J Visser; R H Beelen; N Van Rooijen; C D Dijkstra; S Meyer
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

8.  Colony-stimulating activity from the new metastatic TS/A cell line and its high- and low-metastatic clonal derivatives.

Authors:  G Nicoletti; P Brambilla; C De Giovanni; P L Lollini; B Del Re; A Marocchi; P Mocarelli; G Prodi; P Nanni
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

Review 9.  Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences.

Authors:  Janesh Pillay; Tamar Tak; Vera M Kamp; Leo Koenderman
Journal:  Cell Mol Life Sci       Date:  2013-02-20       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.